Clinical Trial Update: Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance [Phase 4]

View source ↗

Summary

Phase 4 trial from Duke University evaluating a melatonin receptor agonist on sleep latency and inflammation/insulin resistance in insomnia; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Melatonin receptor agonist

Snippet

Sponsor: Duke University | Conditions: Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2014-12-09